Get the Stockscreener App
6.03
3.21%
-0.20
After Hours:
6.15
0.12
+1.99%
Biodesix Inc stock is traded at $6.03, with a volume of 97,290.
It is down -3.21% in the last 24 hours and down -21.43% over the past month.
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Covid tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
See More
Previous Close:
$6.23
Open:
$6.18
24h Volume:
97,290
Relative Volume:
0.71
Market Cap:
$47.97M
Revenue:
$49.09M
Net Income/Loss:
$-52.15M
P/E Ratio:
-9.2769
EPS:
-0.65
Net Cash Flow:
$-45.93M
1W Performance:
-10.27%
1M Performance:
-21.43%
6M Performance:
+11.01%
1Y Performance:
-79.21%
1-Day Range:
$5.61
$6.3422
1-Week Range:
$5.61
$6.9176
52-Week Range:
$3.436
$31.00
Biodesix Inc Stock (BDSX) Company Profile
Name
Biodesix Inc
Sector
Industry
Phone
303-417-0500
Address
919 WEST DILLON ROAD, LOUISVILLE
Compare BDSX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BDSX
Biodesix Inc
|
6.03 | 49.56M | 49.09M | -52.15M | -45.93M | -0.65 |
|
TMO
Thermo Fisher Scientific Inc
|
620.72 | 229.63B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
236.59 | 166.25B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
706.83 | 54.48B | 4.17B | 1.03B | 940.22M | 12.61 |
|
A
Agilent Technologies Inc
|
147.60 | 40.52B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
IQV
Iqvia Holdings Inc
|
240.53 | 39.95B | 15.90B | 1.28B | 2.21B | 7.2842 |
Biodesix Inc Stock (BDSX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-14-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Sep-16-24 | Initiated | Scotiabank | Sector Outperform |
| Jul-26-24 | Initiated | Craig Hallum | Buy |
| May-13-24 | Initiated | TD Cowen | Buy |
| May-03-24 | Initiated | Lake Street | Buy |
| Nov-17-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-23-20 | Initiated | BTIG Research | Buy |
| Nov-23-20 | Initiated | Canaccord Genuity | Buy |
| Nov-23-20 | Initiated | Morgan Stanley | Overweight |
| Nov-23-20 | Initiated | William Blair | Outperform |
View All
Biodesix Inc Stock (BDSX) Latest News
Fundamentals Check: Why analysts recommend Modine Manufacturing Company MMF stockJuly 2025 Market Mood & Free Real-Time Market Sentiment Alerts - moha.gov.vn
Biodesix Jumps 46% As Insider Buying, Retail Optimism Offset Scotiabank Target Cut - MSN
Biodesix CFO sells $22,794 in stock - MSN
BDSX Stock Rises After Publication of Study Data for Nodify CDT Test - MSN
Biodesix, Inc. at Risk: How a Federal Shutdown Could Disrupt Revenue and Growth - MSN
Options Flow: What dividend safety score for Biodesix Inc stock2025 Top Decliners & Low Risk High Win Rate Picks - moha.gov.vn
Analyst Calls: Why analysts upgrade Biodesix Inc stock2025 Price Action Summary & Growth Focused Entry Reports - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Biodesix, Inc. (NASDAQ:BDSX) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Biodesix Inc. stock split again soonJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - Улправда
Biodesix, Inc. (NASDAQ:BDSX) Q4 2024 Earnings Call Transcript - MSN
Is Biodesix Inc. stock attractive for retirement portfoliosGap Down & Safe Capital Growth Stock Tips - Улправда
Why Biodesix Inc. stock is considered a top pick2025 Valuation Update & Precise Trade Entry Recommendations - DonanımHaber
Price Action: Can Biodesix Inc. stock continue upward trendEarnings Recap Summary & AI Enhanced Trading Signals - Улправда
What dividend safety score for Biodesix Inc. stockIPO Watch & Weekly Return Optimization Alerts - DonanımHaber
Why retail investors favor Biodesix Inc. stockTrade Performance Summary & Step-by-Step Swing Trade Plans - DonanımHaber
Is Biodesix Inc. stock affected by interest rate hikes2025 Technical Patterns & Smart Swing Trading Alerts - Улправда
Will Biodesix Inc. stock attract ESG investors2025 Major Catalysts & Fast Moving Trade Plans - DonanımHaber
Biodesix and Bio-Rad Laboratories Team Up on Droplet Digital PCR Assays - Medical Product Outsourcing
Biodesix announces expanded Bio-Rad Laboratories partnership agreement to develop Droplet Digital™ PCR high complexity assays - MSN
Is Biodesix Stock Built to Withstand More Downside? - Trefis
Biodesix chief commercial officer sells shares worth $16,198 - MSN
Loss Report: Can Biodesix Inc stock continue upward trendTake Profit & Weekly Watchlist for Hot Stocks - BỘ NỘI VỤ
Would You Still Hold Biodesix Stock If It Fell 30%? - Trefis
Wall Street Analysts Believe Biodesix (BDSX) Could Rally 325.67%: Here's is How to Trade - Eastern Progress
BDSX FinancialsIncome Statement - Quiver Quantitative
Biodesix, Inc. to Present Clinical Data for Nodify Lung® Tests and New ESR1 Assay at Major Oncology Conferences - Quiver Quantitative
Biodesix to Present New Data at Two Major Upcoming Scientific Meetings - GlobeNewswire
Will Biodesix Inc. stock deliver strong dividend growth2025 Major Catalysts & Safe Capital Growth Plans - Newser
Will Biodesix Inc. stock gain from strong economy2025 Macro Impact & Daily Volume Surge Signals - Newser
Biodesix, Inc.'s (NASDAQ:BDSX) Shares Leap 27% Yet They're Still Not Telling The Full Story - simplywall.st
Macro Review: Is Biodesix Inc. stock affected by interest rate hikesPortfolio Return Summary & Daily Profit Maximizing Tips - BỘ NỘI VỤ
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Can Biodesix Inc. stock continue upward trendWeekly Trade Recap & Free Risk Controlled Daily Trade Plans - moha.gov.vn
Biodesix, Inc. (NASDAQ:BDSX) Given Average Recommendation of “Moderate Buy” by Analysts - Defense World
Biodesix Reports Strong Q3 2025 Revenue Growth - MSN
Is Biodesix Inc. stock attractive for hedge fundsMarket Volume Summary & Weekly Momentum Stock Picks - newser.com
What drives Biodesix Inc stock priceEconomic Indicators Overview & Rapid Wealth Building Tips - earlytimes.in
Can OBSC Perfection Limited Beat EPS Estimates in the Next QuarterTechnical Breakout Signals & Free High Impact Stock Picks - earlytimes.in
Is Biodesix Inc. a candidate for recovery playJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Advanced analytics toolkit walkthrough for Biodesix Inc.2025 Trading Volume Trends & Real-Time Market Sentiment Alerts - newser.com
Top chart patterns to watch in Biodesix Inc.Quarterly Market Summary & Reliable Breakout Forecasts - newser.com
Is Biodesix Inc. stock a bargain at current levelsWeekly Market Summary & Stock Market Timing Techniques - newser.com
Biodesix Inc. recovery potential after sell offJuly 2025 Selloffs & Free Fast Gain Swing Trade Alerts - newser.com
Is Biodesix Inc. stock a good choice for value investorsPortfolio Gains Report & Comprehensive Market Scan Reports - newser.com
Is Biodesix Inc. stock a defensive play in 2025Portfolio Update Report & Growth Oriented Trading Recommendations - newser.com
Biodesix Inc Stock (BDSX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Biodesix Inc Stock (BDSX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Pestano Gary Anthony | Chief Development Officer |
Nov 10 '25 |
Sale |
7.62 |
23 |
175 |
7,939 |
| O'Kane Kieran | Chief Commercial Officer |
Nov 10 '25 |
Sale |
7.62 |
25 |
190 |
7,362 |
| Hutton Scott | President & CEO |
Nov 10 '25 |
Sale |
7.62 |
189 |
1,440 |
37,311 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Nov 10 '25 |
Sale |
7.62 |
50 |
381 |
13,147 |
| SCHULER JACK W | Director |
Sep 19 '25 |
Buy |
7.04 |
142,045 |
999,997 |
1,380,745 |
| SCHULER JACK W | Director |
Sep 17 '25 |
Buy |
6.04 |
15,317 |
92,571 |
1,235,644 |
| SCHULER JACK W | Director |
Sep 18 '25 |
Buy |
6.17 |
3,056 |
18,854 |
1,238,700 |
| SCHULER JACK W | Director |
Aug 29 '25 |
Buy |
0.43 |
3,488,372 |
1,500,000 |
24,406,546 |
| Cowie Robin Harper | CFO, Sec'y & Treasurer |
Aug 13 '25 |
Sale |
0.42 |
988 |
411 |
250,794 |
| Hutton Scott | President & CEO |
Aug 13 '25 |
Sale |
0.42 |
3,772 |
1,570 |
728,824 |
2.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):